HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older.
- People who have been recently diagnosed with an acute HIV-1 infection, confirmed through specific blood test results that indicate early-stage infection (the trial site can explain which stage applies in each case).
- People willing to sign a consent form allowing their biological samples to be stored and used for genetic testing.
- People willing to sign a separate consent form for certain sample collection procedures, which may include a blood filtering procedure, a bowel examination with tissue samples taken, a lymph node biopsy, and a spinal fluid sample, along with storage of those samples.
- People with female reproductive capacity who are willing to use adequate contraception during the trial.
Who may not be able to join:
- People who have a medical reason that prevents them from taking the planned HIV treatment combination — for example, reduced kidney function (confirm with trial site).
- People who have a mental health condition that, in the opinion of the trial investigator, could make it difficult to follow the treatment plan or study procedures, or to make an informed decision about taking part.
- People who are taking medication that suppresses the immune system, or who have another condition that causes immune deficiency.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0031642970500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The establishment of a prospective cohort study of patients that initiate cART during the acute infection phase, aiming at achieving "post-treatment viral remission".
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.